{
  "url": "https://www.law.cornell.edu/regulations/new-york/12-NYCRR-440.2",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 12 ยง 440.2 - Definitions",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 12 ยง 440.2 - Definitions\n\nState Regulations\n(a) \"Average\n\nWholesale Price\" or \"AWP\" means the average wholesale price of a prescription\ndrug as provided in the most current release of the Red Book published by\n\nThomson Reuters or Medi-Span Master Drug Database by Wolters Kluwar Health or\nany successor publisher, on the day a prescription drug is dispensed or other\nnationally recognized drug pricing index adopted by the Chair or Chair's\ndesignee. (b) \"Brand name drug\"\nmeans a drug for which an application is approved under the Federal Food, Drug, and Cosmetic Act Section 505(c). (c) \"Calculated cost\" means the Average\n\nWholesale Price for the national drug code of the prescription drug or medicine\non the day it was dispensed plus a dispensing fee. For brand name drugs the\n\nCalculated cost shall be AWP minus twelve percent of the Average Wholesale\nprice plus a dispensing fee of four dollars. For generic drugs the Calculated\ncost shall be AWP minus twenty percent plus a dispensing fee of five\ndollars. (d) \"Contract price\" means\nthe maximum amount that a designated pharmacy (as set forth in section\n440.3\nof this Part) will pay a\npharmacy for generic drugs and brand name drugs that have generic versions\navailable (multi-source brands). (e) \"Controlled substance\" has the meaning\nprovided in Public Health Law Section 3306. (f) \"Formulary\" means the New York Workers'\nCompensation Formulary which is a list of drugs for work-related injuries that\nis incorporated by reference in section\n441.2\nof this Part and that must\nbe used to prescribe medication for all Disability events. The Formulary\nincludes medications available in Phase A and B; and, also includes a list of\nmedications available for Perioperative periods that may be prescribed without\n\nPrior Authorization during the applicable Phase or Perioperative\nperiod. (g) \"Generic drug\" means an\nFDA-approved drug that is therapeutically equivalent to a brand name drug, as\ndetermined by the FDA's designation of the drug with the Therapeutic\n\nEquivalence Evaluation Code designation as an \"A\" product in the \"Approved Drug\n\nProducts with Therapeutic Equivalence Evaluations\" (commonly referred to as the\n\nOrange Book), irrespective of dosage for the route of administration (oral, topical or systemic) prescribed. A brand name drug may not be dispensed when a\ngeneric version of the same active ingredient is commercially available in a\ndifferent strength/ dosage. (h) \"Independent pharmacy\" means a pharmacy (including a remote pharmacy) that is\nnot part of a pharmacy chain. (i) \"Insurance carrier\" means the State Insurance Fund, stock corporations, mutual\ncorporations or reciprocal insurers with which employers have insured, and any\nspecial fund maintained by the Board that is responsible for paying for medical\ntreatment and care of injured workers, including but not limited to, the\n\nSpecial Fund for Reopened Cases created and governed by Workers' Compensation\n\nLaw Section 25-a and the Uninsured Employers' Fund created and governed by\n\nWorkers' Compensation Law Section 26-a. (j) \"Pharmacy benefit management\" means the\nservices provided to a self-insured employer or insurance carrier, directly or\nthrough another entity, including: (1)\nthe\nnegotiation of the amount to be paid for prescription medicine or drugs by the\nself-insured employer or insurance carrier and the amount paid to an\nindependent pharmacy, pharmacy chain, or remote pharmacy dispensing\nprescription medicine or drugs; (2)\nprocurement of prescription medicines or drugs to be dispensed to injured\nemployees; or\n(3)\nthe\nadministration or management of prescription medicine or drug benefits, including, but not limited to, any of the following: (i) mail service pharmacy; (ii)\nclaims processing, New York Pharmacy\n\nFormulary administration and prior authorization review, retail network\ncontracting and management, or payment of claims to pharmacies for dispensing\nprescription medicines or drugs; (iii)\npatient compliance, therapeutic\nintervention, or generic substitution programs; (iv)\ndisease management; and\n(v) retrospective review. (k) \"Pharmacy benefit\nmanager\" means any entity that performs pharmacy benefit management for a\nself-insured employer or insurance carrier. (l) \"Pharmacy chain\" means any entity that\nhas been designated by a carrier or self-insured employer under section\n440.3\n(a) of this\n\nPart that is: (1)\na group of pharmacies\n(including remote pharmacies) under common ownership; or\n(2)\na group of pharmacies (including remote\npharmacies) linked to the same company via franchise agreements. (m) \"Pharmacy Processing Agent\"\nmeans person or entity that contracts with a pharmacy as permitted by law, establishing an agent or assignee relationship, to process claims and act on\nbehalf of the pharmacy under the terms and conditions of a contract related to\nservices being billed. Such contracts may permit the agent or assignee to\nsubmit billings, request reconsideration, receive reimbursement, and seek\nmedical dispute resolution for the pharmacy services billed. (n) \"Remote pharmacy\" means any pharmacy that\nsells anywhere in New York State by mail, phone and/or Internet. (o) \"Repackaging\" is the act of taking a\nfinished drug product from the container in which it was distributed by the\noriginal manufacturer and placing it into a different container without further\nmanipulation of the drug. Repackaging also includes the act of placing the\ncontents of multiple containers (e.g., vials) of the same finished drug product\ninto one container when the container does not include other\ningredients. (p) ''Rural area''\nmeans counties within the state having a population of less than two hundred\nthousand, and the municipalities as are found therein, and in counties having a\npopulation of two hundred thousand or greater, ''rural areas'' means towns with\npopulation densities of one hundred fifty persons or less per square mile, and\nthe villages and other municipalities as are found therein. For purposes of\nthis Part, a rural area does not include municipalities which are incorporated\ncities or villages having a population of 2,500 or more. (q) \"Self-insured employer\" means an employer\npermitted by the Chair to pay compensation and medical benefits directly under\nthe provisions of Workers' Compensation Law Section 50(3), (3-a) or\n(4). (r) \"Third party payor\" means\nany self-insured employer, insurance carrier, nonprofit hospital service plan, health care service plan, health maintenance organization, or any person or\nother entity which provides payment for medical and related services. (s) \"Usual and Customary price\" means the\nretail price charged to the general public for a prescription drug. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 12\nยง\n440.2\n\nAmended\n\nNew\n\nYork State Register April 17, 2019/Volume XLI, Issue 16, eff. 4/17/2019\n\nAmended\n\nNew\n\nYork State Register April 17, 2019/Vol. XLI, Issue 16, eff. 10/1/2019\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 20520
}